Advances in antiretroviral therapy (ART) has led to HIV being a manageable and preventable condition and provides the tools that might lead to an end of the HIV pandemic. Despite these advances, in the United States there were approximately 30 000 new infections in 2022, less than 70% of people living with HIV were virologically suppressed, and only 30% of those eligible for preexposure prophylaxis (PrEP) were receiving it. Prioritizing efforts on the significant disparities in access to care and the delivery of equitable health care are essential for future elimination goals.
Source link
